Previous Close | 1.95 |
1-Year Change | -94.54% |
6-Months Change | -83.12% |
3-Months Change | -53.01% |
Moving Avg (50d) | 1.4688 |
Moving Avg (200d) | 9.0406 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 3.64M |
Beta (3-Years) | 0.99 |
Revenue Growth (ttm) | 10.27% |
Net Profit Margin (ttm) | -191.82% |
Return On Assets (ttm) | -145.17% |
EPS (ttm) | -22.12 |
PE Ratio (ttm) | -0.09 |
Dividend Yield | % |
Asset Description: | Nuwellis, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Buy |
Forecast Date: | 2024-10-21 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
1.911 | 1.853 | 1.814 | 1.755 | 1.658 | 1.56 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Health Care Technology |
Country: | United States |